{
    "2019-09-06": [
        [
            {
                "time": "2019-09-06",
                "original_text": "After Hours Most Active for Sep 6, 2019: GPS, AEO, PFE, F, V, BAC",
                "features": {
                    "keywords": [
                        "Most Active",
                        "PFE"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "finance",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-09-06",
                "original_text": "Pfizer is a Top Drugmaker: Is it the Right Time to Buy It?",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Top Drugmaker",
                        "Buy"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-09-06",
                "original_text": "Health Care Sector Update for 09/06/2019: NTGN, MYOV, VIVE, JNJ, PFE, ABT, MRK, AMGN",
                "features": {
                    "keywords": [
                        "Health Care Sector",
                        "Update",
                        "PFE"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-09-06",
                "original_text": "UPDATE 1-Novartis joins Pfizer with FDA fast-track tag for lung cancer hopeful",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Pfizer",
                        "FDA",
                        "fast-track",
                        "lung cancer"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}